TABLE OF CONTENTS
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF EUROPE PEN NEEDLES MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 EUROPE PEN NEEDLES MARKET: GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 DBMR MARKET POSITION GRID
2.7 MULTIVARIATE MODELING
2.8 PRODUCTS LIFELINE CURVE
2.9 VENDOR SHARE ANALYSIS
2.10 SECONDARY SOURCES
2.11 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.1.1 INCREASING PREVALENCE OF DIABETES
3.1.2 INCREASING GERIATRIC POPULATION
3.1.3 RISING GOVERNMENT INITIATIVES
3.2 RESTRAINT
3.2.1 PREFERENCE FOR ALTERNATIVE MODES OF DRUG DELIVERY
3.3 OPPORTUNITIES
3.3.1 RISE IN AWARENESS AMONG THE POPULATION
3.3.2 INCREASING BIOSIMILAR DRUG AVAILABILITY
3.4 CHALLENGES
3.4.1 REUSE OF PEN NEEDLES
3.4.2 STRICT REGULATORY REQUIREMENTS
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
6 EUROPE PEN NEEDLES MARKET, BY PRODUCT TYPE
6.1 OVERVIEW
6.2 STANDARD PEN NEEDLES
6.3 SAFETY PEN NEEDLES
7 EUROPE PEN NEEDLES MARKET, BY PRODUCT LENGTH
7.1 OVERVIEW
7.2 MEDIUM LENGTH
7.3 NANO LENGTH
7.4 LONG LENGTH
8 EUROPE PEN NEEDLES MARKET, BY USABILITY
8.1 OVERVIEW
8.2 REUSABLE
8.3 DISPOSABLE
9 EUROPE PEN NEEDLES MARKET, BY APPLICATION
9.1 OVERVIEW
9.2 DIABETES
9.3 GROWTH HORMONE DEFICIENCY
9.4 OTHERS
10 EUROPE PEN NEEDLES MARKET, BY THERAPY
10.1 OVERVIEW
10.2 INSULIN
10.3 GLUCAGON-LIKE PEPTIDE-1
10.4 GROWTH HORMONES
10.5 OTHERS
11 EUROPE PEN NEEDLES MARKET, BY END USER
11.1 OVERVIEW
11.2 HOME HEALTHCARE
11.3 HOSPITALS
11.4 CLINICS
11.5 OTHERS
?
12 EUROPE PEN NEEDLES MARKET, BY GEOGRAPHY
12.1 EUROPE
12.1.1 GERMANY
12.1.2 FRANCE
12.1.3 ITALY
12.1.4 U.K.
12.1.5 SPAIN
12.1.6 RUSSIA
12.1.7 NETHERLANDS
12.1.8 SWITZERLAND
12.1.9 BELGIUM
12.1.10 TURKEY
12.1.11 REST OF EUROPE
13 EUROPE PEN NEEDLES MARKET, COMPANY LANDSCAPE
13.1 COMPANY SHARE ANALYSIS: EUROPE
14 COMPANY PROFILE
14.1 NOVO NORDISK A/S
14.1.1 COMPANY SNAPSHOT
14.1.2 REVENUE ANALYSIS
14.1.3 COMPANY SHARE ANALYSIS
14.1.4 PRODUCT PORTFOLIO
14.1.5 RECENT DEVELOPMENTS
14.2 SANOFI
14.2.1 COMPANY SNAPSHOT
14.2.2 REVENUE ANALYSIS
14.2.3 COMPANY SHARE ANALYSIS
14.2.4 PRODUCT PORTFOLIO
14.2.5 RECENT DEVELOPMENTS
14.3 ELI LILLY AND COMPANY
14.3.1 COMPANY SNAPSHOT
14.3.2 REVENUE ANALYSIS
14.3.3 COMPANY SHARE ANALYSIS
14.3.4 PRODUCT PORTFOLIO
14.3.5 RECENT DEVELOPMENTS
14.4 BD
14.4.1 COMPANY SNAPSHOT
14.4.2 REVENUE ANALYSIS
14.4.3 COMPANY SHARE ANALYSIS
14.4.4 PRODUCT PORTFOLIO
14.4.5 RECENT DEVELOPMENTS
14.5 A. MENARINI DIAGNOSTICS SRL
14.5.1 COMPANY SNAPSHOT
14.5.2 PRODUCT PORTFOLIO
14.5.3 RECENT DEVELOPMENT
14.6 ALLISON MEDICAL, INC.
14.6.1 COMPANY SNAPSHOT
14.6.2 PRODUCT PORTFOLIO
14.6.3 RECENT DEVELOPMENT
14.7 B. BRAUN MELSUNGEN AG
14.7.1 COMPANY SNAPSHOT
14.7.2 REVENUE ANALYSIS
14.7.3 PRODUCT PORTFOLIO
14.7.4 RECENT DEVELOPMENTS
14.8 DIGITAL MEDICS PTY LTD
14.8.1 COMPANY SNAPSHOT
14.8.2 PRODUCT PORTFOLIO
14.8.3 RECENT DEVELOPMENTS
14.9 DOMREX PHARMA INC.
14.9.1 COMPANY SNAPSHOT
14.9.2 PRODUCT PORTFOLIO
14.9.3 RECENT DEVELOPMENT
14.10 FACET MEDICAL TECHNOLOGIES
14.10.1 COMPANY SNAPSHOT
14.10.2 PRODUCT PORTFOLIO
14.10.3 RECENT DEVELOPMENT
14.11 HTL- STREFA S.A.
14.11.1 COMPANY SNAPSHOT
14.11.2 PRODUCT PORTFOLIO
14.11.3 RECENT DEVELOPMENTS
14.12 KD MEDICAL GMBH HOSPITAL PRODUCTS
14.12.1 COMPANY SNAPSHOT
14.12.2 PRODUCT PORTFOLIO
14.12.3 RECENT DEVELOPMENT
14.13 LDI LTD., LLC
14.13.1 COMPANY SNAPSHOT
14.13.2 PRODUCT PORTFOLIO
14.13.3 RECENT DEVELOPMENTS
?
14.14 MEDEXEL CO., LTD.
14.14.1 COMPANY SNAPSHOT
14.14.2 PRODUCT PORTFOLIO
14.14.3 RECENT DEVELOPMENT
14.15 OWEN MUMFORD LTD
14.15.1 COMPANY SNAPSHOT
14.15.2 PRODUCT PORTFOLIO
14.15.3 RECENT DEVELOPMENT
14.16 PENDIQ GMBH
14.16.1 COMPANY SNAPSHOT
14.16.2 PRODUCT PORTFOLIO
14.16.3 RECENT DEVELOPMENT
14.17 STAT MEDICAL DEVICES.
14.17.1 COMPANY SNAPSHOT
14.17.2 PRODUCT PORTFOLIO
14.17.3 RECENT DEVELOPMENT
14.18 TERUMO CORPORATION
14.18.1 COMPANY SNAPSHOT
14.18.2 REVENUE ANALYSIS
14.18.3 PRODUCT PORTFOLIO
14.18.4 RECENT DEVELOPMENTS
14.19 VOGT MEDICAL
14.19.1 COMPANY SNAPSHOT
14.19.2 PRODUCT PORTFOLIO
14.19.3 RECENT DEVELOPMENT
14.20 WILHELM HASELMEIER GMBH & CO. KG
14.20.1 COMPANY SNAPSHOT
14.20.2 PRODUCT PORTFOLIO
14.20.3 RECENT DEVELOPMENTS
14.21 YPSOMED AG
14.21.1 COMPANY SNAPSHOT
14.21.2 REVENUE ANALYSIS
14.21.3 PRODUCT PORTFOLIO
14.21.4 RECENT DEVELOPMENTS
15 QUESTIONNAIRE
16 RELATED REPORTS